Bank of New York Mellon’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.14M | Buy |
508,880
+24,844
| +5% | +$95.8K | ﹤0.01% | 2914 |
|
|
2026
Q1 | $1.7M | Sell |
484,036
-26,171
| -5% | -$107K | ﹤0.01% | 2893 |
|
|
2025
Q4 | $1.72M | Buy |
510,207
+7,129
| +1% | +$18.5K | ﹤0.01% | 2929 |
|
|
2025
Q3 | $659K | Buy |
503,078
+15,896
| +3% | +$16.5K | ﹤0.01% | 3440 |
|
|
2025
Q2 | $349K | Sell |
487,182
-12,431
| -2% | -$9.76K | ﹤0.01% | 3725 |
|
|
2025
Q1 | $734K | Sell |
499,613
-478,522
| -49% | -$1.14M | ﹤0.01% | 3238 |
|
|
2024
Q4 | $4.33M | Buy |
978,135
+65,357
| +7% | +$265K | ﹤0.01% | 2369 |
|
|
2024
Q3 | $3.76M | Sell |
912,778
-130,600
| -13% | -$702K | ﹤0.01% | 2436 |
|
|
2024
Q2 | $6.8M | Buy |
1,043,378
+5,960
| +0.6% | +$42.2K | ﹤0.01% | 2162 |
|
|
2024
Q1 | $9.04M | Sell |
1,037,418
-90,600
| -8% | -$1.1M | ﹤0.01% | 2012 |
|
|
2023
Q4 | $12.9M | Sell |
1,128,018
-91,968
| -8% | -$910K | ﹤0.01% | 1833 |
|
|
2023
Q3 | $11.7M | Sell |
1,219,986
-45,578
| -4% | -$447K | ﹤0.01% | 1849 |
|
|
2023
Q2 | $13.5M | Sell |
1,265,564
-389
| -0% | -$4.18K | ﹤0.01% | 1785 |
|
|
2023
Q1 | $13.3M | Sell |
1,265,953
-673
| -0.1% | -$7.54K | ﹤0.01% | 1773 |
|
|
2022
Q4 | $15.7M | Sell |
1,266,626
-370,246
| -23% | -$4.2M | ﹤0.01% | 1674 |
|
|
2022
Q3 | $17M | Sell |
1,636,872
-29,193
| -2% | -$331K | ﹤0.01% | 1598 |
|
|
2022
Q2 | $19.2M | Buy |
1,666,065
+591,516
| +55% | +$6.97M | ﹤0.01% | 1550 |
|
|
2022
Q1 | $13.5M | Buy |
1,074,549
+194,261
| +22% | +$2.23M | ﹤0.01% | 1910 |
|
|
2021
Q4 | $10.3M | Buy |
880,288
+87,212
| +11% | +$1.07M | ﹤0.01% | 2085 |
|
|
2021
Q3 | $10.4M | Sell |
793,076
-26,376
| -3% | -$341K | ﹤0.01% | 2100 |
|
|
2021
Q2 | $10.5M | Sell |
819,452
-176,378
| -18% | -$2.02M | ﹤0.01% | 2107 |
|
|
2021
Q1 | $11.1M | Buy |
995,830
+184,454
| +23% | +$1.95M | ﹤0.01% | 2029 |
|
|
2020
Q4 | $9.24M | Buy |
811,376
+159,543
| +24% | +$1.75M | ﹤0.01% | 2049 |
|
|
2020
Q3 | $5.86M | Sell |
651,833
-16,623
| -2% | -$165K | ﹤0.01% | 2133 |
|
|
2020
Q2 | $6.9M | Buy |
668,456
+17,299
| +3% | +$177K | ﹤0.01% | 2046 |
|
|
2020
Q1 | $6.57M | Sell |
651,157
-29,028
| -4% | -$341K | ﹤0.01% | 1927 |
|
|
2019
Q4 | $9.05M | Buy |
680,185
+14,291
| +2% | +$158K | ﹤0.01% | 2036 |
|
|
2019
Q3 | $5.72M | Buy |
665,894
+15,782
| +2% | +$153K | ﹤0.01% | 2214 |
|
|
2019
Q2 | $7.11M | Sell |
650,112
-72,374
| -10% | -$811K | ﹤0.01% | 2165 |
|
|
2019
Q1 | $8.19M | Sell |
722,486
-6,753
| -0.9% | -$75.4K | ﹤0.01% | 2078 |
|
|
2018
Q4 | $6.33M | Sell |
729,239
-18,643
| -2% | -$214K | ﹤0.01% | 2157 |
|
|
2018
Q3 | $11.6M | Buy |
747,882
+12,796
| +2% | +$202K | ﹤0.01% | 1929 |
|
|
2018
Q2 | $11.8M | Sell |
735,086
-10,800
| -1% | -$160K | ﹤0.01% | 1932 |
|
|
2018
Q1 | $9.64M | Buy |
745,886
+6,140
| +0.8% | +$76.5K | ﹤0.01% | 1995 |
|
|
2017
Q4 | $9.29M | Sell |
739,746
-6,025
| -0.8% | -$78.7K | ﹤0.01% | 2028 |
|
|
2017
Q3 | $9.85M | Buy |
745,771
+4,902
| +0.7% | +$67.5K | ﹤0.01% | 1996 |
|
|
2017
Q2 | $11.7M | Buy |
740,869
+3,398
| +0.5% | +$49.4K | ﹤0.01% | 1873 |
|
|
2017
Q1 | $10.5M | Buy |
737,471
+7,839
| +1% | +$107K | ﹤0.01% | 1940 |
|
|
2016
Q4 | $9.34M | Buy |
729,632
+35,647
| +5% | +$450K | ﹤0.01% | 1988 |
|
|
2016
Q3 | $9.23M | Sell |
693,985
-17,566
| -2% | -$205K | ﹤0.01% | 1922 |
|
|
2016
Q2 | $7.79M | Buy |
711,551
+11,096
| +2% | +$108K | ﹤0.01% | 1977 |
|
|
2016
Q1 | $6.42M | Sell |
700,455
-12,567
| -2% | -$104K | ﹤0.01% | 2056 |
|
|
2015
Q4 | $6.92M | Buy |
713,022
+2,848
| +0.4% | +$27.5K | ﹤0.01% | 2033 |
|
|
2015
Q3 | $6.2M | Sell |
710,174
-114,974
| -14% | -$1.07M | ﹤0.01% | 2118 |
|
|
2015
Q2 | $8.33M | Buy |
825,148
+41,117
| +5% | +$478K | ﹤0.01% | 2056 |
|
|
2015
Q1 | $10.5M | Buy |
784,031
+21,854
| +3% | +$287K | ﹤0.01% | 1927 |
|
|
2014
Q4 | $9.78M | Buy |
762,177
+37,864
| +5% | +$433K | ﹤0.01% | 1928 |
|
|
2014
Q3 | $7.86M | Buy |
724,313
+39,795
| +6% | +$456K | ﹤0.01% | 2042 |
|
|
2014
Q2 | $8.79M | Buy |
684,518
+33,190
| +5% | +$361K | ﹤0.01% | 2000 |
|
|
2014
Q1 | $6.72M | Buy |
651,328
+56,966
| +10% | +$641K | ﹤0.01% | 2147 |
|
|
2013
Q4 | $5.78M | Buy |
594,362
+14,196
| +2% | +$127K | ﹤0.01% | 2205 |
|
|
2013
Q3 | $5.75M | Buy |
580,166
+42,379
| +8% | +$416K | ﹤0.01% | 2160 |
|
|
2013
Q2 | $4.47M | Buy |
+537,787
| New | +$6.52M | ﹤0.01% | 2250 |
|
Other funds holding IRWD
IC
WCM
RWM
N
Bank of New York Mellon's IRWD Position: Q2 2026 in Review
Bank of New York Mellon increased its Ironwood Pharmaceuticals (IRWD) stake by 5.1% in Q2 2026, buying an estimated $95.8K and bringing the position to 508,880 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2914.
Bank of New York Mellon first reported a position in IRWD in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.2M in Q2 2022. 98 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Bank of New York Mellon held 508,880 shares of Ironwood Pharmaceuticals worth $2.14M as of Q2 2026.
- Bank of New York Mellon bought 24,844 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $95.8K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2914 holding.
- Bank of New York Mellon first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Ironwood Pharmaceuticals position peaked at $19.2M in Q2 2022.
- 98 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.